Related Experiment Videos
Do indium 111-labeled polymorphonuclear leukocytes detect neutrophil-prominent, fibrosing lung disease in rats?
Abstract:
The role of polymorphonuclear leukocytes (PMNs) in fibrotic lung disease remains poorly defined, but PMN prominence may predict a poor response to therapy in some patients. The bleomycin injury to rats represents a model of PMN-prominent alveolitis leading to fibrosis. We examined a method of identifying the alveolitis during its PMN-prominent phase with indium 111-labeled homologous PMNs (In-PMNs). When pairs of injured and uninjured rats were compared, greater activity was consistently found persisting in the lung images of the injured rats, both several hours (early) and a day (late) after injection of In-PMNs. Differences could likewise be identified when lung activity was normalized to activity of the injectate, the spleen, and variably the liver, as determined from organ images. These differences in gamma camera images were supported by direct measurement of activity in organs obtained by killing the animals after scanning. When groups of animals were compared, lung/spleen ratios appeared to most consistently differentiate the group of normal animals from those with alveolitis. These methods may provide a noninvasive means of identifying PMN prominence in the lung, which occurs in some fibrotic processes.
Insights
This study introduces a noninvasive imaging method using indium 111-labeled polymorphonuclear leukocytes (PMNs) to detect PMN accumulation in lung injury models. This technique shows promise for identifying PMN-driven lung inflammation in fibrotic lung diseases.
Area of Science:
- Pulmonary Medicine
- Medical Imaging
- Immunology
Background:
- The role of polymorphonuclear leukocytes (PMNs) in fibrotic lung disease is unclear.
- PMN presence may indicate a poor therapeutic response in some patients.
- Bleomycin-induced lung injury in rats models PMN-prominent alveolitis and fibrosis.
Purpose of the Study:
- To evaluate a noninvasive method for identifying PMN-prominent alveolitis.
- To utilize indium 111-labeled homologous PMNs (In-PMNs) for imaging.
Main Methods:
- Rats with bleomycin-induced lung injury were injected with In-PMNs.
- Gamma camera imaging was used to assess In-PMN distribution in injured versus uninjured rats.
- Lung activity was normalized to injectate, spleen, and liver for comparison.
- Direct organ activity measurements confirmed imaging findings.
Main Results:
- Injured rats consistently showed higher In-PMN lung activity compared to uninjured controls, both early and late post-injection.
- Normalized lung activity, particularly the lung/spleen ratio, effectively differentiated between normal and alveolitis groups.
- Imaging findings were corroborated by ex vivo organ activity measurements.
Conclusions:
- In-PMN imaging offers a potential noninvasive approach to detect PMN accumulation in the lungs.
- This method could aid in identifying PMN prominence in fibrotic lung conditions.
- Further research may establish its clinical utility in managing fibrotic lung diseases.